(2e)-3-(1-Benzothiophen-3-yl)prop-2-enoic acid, 98%, 50mg

N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine, 98%, 10g

1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate, 95%, 1g

5-Methylbenzo[b]thiophene, 97.0%, 5g

Ethyl 2-(4-Fluorophenyl)-4-methylthiazole-5-carboxylate, 98.0%, 1g

Microcrystalline cellulose, for thin layer chromatography, 100 g, plastic packaging.

(4-(Piperidin-1-ylmethyl)phenyl)methanamine, 97%, 500mg

1-Chloro-2-methyl-4-nitrobenzene, 98.0%, 10g

4-Oxopiperidine-3-carbonitrile hydrochloride, 95.0%, 250mg

5-Cyclopropyl-1,2,4-oxadiazole-3-carboxylic acid, 95%, 1g

ethyl 3-hydroxyquinoxaline-2-carboxylate, 95.0%, 1g

Fmoc-L-4,4-difluoroproline, 97.0%, 5g

4-Oxo-4-((5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid, 97.0%, 100mg